Margaret A. Ponder

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A

Lois M. Mulligan, John B. Kwok, Catherine S. Healey et al. · Nature · 1993 · 2K citations

Medicine, Genetics, Molecular Genetics +16

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

Lois M. Mulligan, Charis Eng, Catherine S. Healey et al. · Nature Genetics · 1994 · 651 citations

Life Sciences, Genetics, Molecular Genetics +16

Point mutation within the tyrosine kinase domain of the <i>RET</i> proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours

Charis Eng, Darrin P. Smith, Lois M. Mulligan et al. · Human Molecular Genetics · 1994 · 536 citations

Medicine, Molecular Genetics, Oncology +17

An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.

Douglas F. Easton, Margaret A. Ponder, SM Huson et al. · PubMed · 1993 · 389 citations

Medicine, Genetics, Molecular Genetics +10

A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.

Charis Eng, Dean P. Smith, Lois M. Mulligan et al. · PubMed · 1995 · 253 citations

Medicine, Genetics, Molecular Genetics +17